AACR: Adjuvant Atezolizumab + Bevacizumab Beneficial in Liver Cancer
TUESDAY, April 18, 2023 (HealthDay News) — For patients with high-risk hepatocellular carcinoma (HCC), adjuvant therapy of atezolizumab with bevacizumab (atezo + bev) prolongs recurrence-free survival, according to a study presented at the annual mee…
Learn MoreFighting Liver Cancer Takes Big Financial Toll: Study
THURSDAY, Feb. 2, 2023 (HealthDay News) — Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis with hepatocellular carcinoma (HCC) ex…
Learn MoreRobotic Resection Cuts Perioperative Morbidity With Liver Cancer
MONDAY, Nov. 28, 2022 (HealthDay News) — Robotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), according to a study publi…
Learn MoreLiver Cancer in Top Five Causes of Cancer Deaths in 90 Countries
THURSDAY, Oct. 13, 2022 (HealthDay News) — Liver cancer is a major cause of death in many countries, according to a study published online Oct. 5 in the Journal of Hepatology.Harriet Rumgay, from the International Agency for Research on Cancer in Lyo…
Learn MoreLiver Cancer Risk May Rise for 2nd-, 3rd-Generation U.S. Mexicans
TUESDAY, Sept. 20, 2022 (HealthDay News) — The risk of hepatocellular carcinoma (HCC) appears to be increased for successive generations of U.S. Mexicans, according to a study presented at the 15th AACR Conference on the Science of Cancer Health Disp…
Learn MoreLa infección con la hepatitis C puede matar, pero menos de un tercio de los pacientes se tratan
MIÉRCOLES, 10 de agosto de 2022 (HealthDay News) — Menos de un tercio de las personas con hepatitis C reciben tratamiento para esta infección, que es potencialmente letal, pero curable, en un plazo de un año tras su diagnóstico, advierte un nuevo inf…
Learn MoreVinculan a las PFAS, unos ‘compuestos permanentes’, con el cáncer de hígado
MIÉRCOLES, 10 de agosto de 2022 (HealthDay News) — Un compuesto llamado sulfato de perfluooctano (PFOS) se ha vinculado con el tipo más común de cáncer de hígado, indica un estudio reciente.El PFOS se utiliza en una amplia variedad de productos del c…
Learn MoreHepatitis C Infection Can Kill, But Less Than a Third of Patients Get Treatment
Vital Signs Aug (HCV) Press Statement_EMBARGOED_ (1).pdfWEDNESDAY, Aug. 10, 2022 (HealthDay News) — Less than one-third of people with hepatitis C get treatment for this potentially deadly, but curable, infection within a year of their diagnosis, a n…
Learn MorePFAS ‘Forever Chemicals’ Are Linked With Liver Cancer
WEDNESDAY, Aug. 10, 2022 (HealthDay News) — A chemical called perfluooctane sulfate (PFOS) has been linked to the most common type of liver cancer, a new study indicates.PFOS are used in a wide range of consumer and industrial products, and are refer…
Learn MoreWalking Off the Weight
Shirley Miller* walks more than two miles on a treadmill nearly every day — not bad for someone attached to an oxygen tank. Miller, in her sixties, has chronic bronchitis. And emphysema. And asthma. People would understand if she decided to take it e…
Learn More